chronic inflammation of multiple peripheral joints for which the “gold standard” drug is methotrexate (MTX). Literature suggests that RA patients’ genetic profile may have a significant role in therapeutic outcome
aims to evaluate frequency and to identify factors which may increase the discontinuation of Methotrexate (MTX) among our Rheumatoid arthritis (RA) patients in Aseer region, KSA. Methods: Across sectional study
left adnexal mass, pouch of Douglas free. Plan of management was Medical treatment by Methotrexate 50 mg IM stat with serial repeating B-hcg after counseling the patient ... urine PH>7. 4. Repeat CBC, RFT, LFT Daily. 5…
present study aims to develop MTX-S (Methotrexate sodium) in situ gels as an effective way for the treatment of rheumatic arthritis (RA). The in situ gels composed of Pluronic
Methotrexate (MTX) is the antifolate that has been in clinical use for decades as a component of the curative regimen of children with acute lymphoblastic leukemia (ALL). In recent years ... chemoresistance. Truly, one…
Methotrexate (MTX) is an antimetabolite of folic acid whose action mechanism consists of competitively inhibiting dihydrofolate reductase (DHFR), a key enzyme for cell proliferation. It is used for the treatment…
anti inflammatory effects of AGE in arthritic conditions not well documented and the Methotrexate (MTX) is an anchor drug used to treat rheumatoid arthritis (RA), but responsiveness is variable ... rats of AGE alone and…
Methotrexate is an immunosuppressive agent that acts as a folic acid analog which competitively inhibits dihydrofolate reductase enzyme. Methotrexate comes after Prednisolone as one of the most commonly prescribed…
considered here was exemplified by modeling the formation of 7-hydroxymethotrexate (7OH-MTX) from methotrexate (MTX) in patients undergoing treatment for psoriasis with MTX. Results: The metabolic ratios
investigate time dependent changes in the formation of 7-hydroxymethotrexate (7OH-MTX) from methotrexate (MTX) in patients undergoing treatment for psoriasis with MTX. Method: This study is a companion piece
most common childhood malignancies representing about one third of all pediatric cancers. Adding methotrexate to leukemia treatment protocols has been associated with an increased survival rate in children with…
Introduction: Methotrexate is one of the most effective agents in chemotherapy regimens for childhood ALL. However, methotrexate has remarkable side effects, which causes complications in various tissues and organs…
Arthritis is a common chronic disease and concern about the adverse eff ect of methotrexate especially hepatotoxicity could be a reason for discontinuation or reducing dose but the result ... result of multiple…
Background: Methotrexate drug is commonly used to treat cancer and caused reproductive damage. Thymoquinone, as a natural component of herbs has many health benefits shown in researches. The present study ... amid to…
Introduction: Methotrexate (MTX) is a disease-modifying anti-rheumatic drug used in the treatment of rheumatoid arthritis (RA). It is the first line drug in the treatment of this disease
patient’s lifespan expansion requires long-term treatment with harmful agents, such as Methotrexate or other immuno-suppressive drugs. The Methotrexate toxicities are based on the duration and cumulative dosing…
Methotrexate (MTX) had been used for many years and complications usually encountered during treatment especially in cancer patients. The aim of the present study was to determine the preventive ... histology of the…
dermis becomes red and swollen. Objectives: To compare and evaluate the uses of methotrexate and other drugs; and their efficiency on psoriasis using various clinical studies. Method: Research for randomised…
synovial inflammation and disability. The most widely used Disease-Modifying Antirheumatic Drug (DMARD) is methotrexate and it continues to be the gold standard. However, the use of high-dose methotrexate ... DMARD for…
Background & Objectives: Methotrexate (MTX) had been used for many years and complications usually encountered during treatment especially in cancer patients. The aim of the present study was to determine ... histology…
present study aims to develop MTX-S (Methotrexate sodium) in situ gels as an effective way for the treatment of Rheumatic Arthritis (RA). Methotrexate has been reportable to cause vertebrate ... thought of risks…
maternal mortality and morbidity. The benefits of medical therapy particularly with single dose methotrexate and the cure rate are high. The objective of the study was to explore the efficiency ... medical management…
Background: Clinical studies in patients with rheumatoid arthritis indicate that subcutaneous methotrexate exhibits a better pharmacokinetic profile than oral methotrexate, and this was associated with greater efficacy…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.